Rheumatology Doctors in Jamaica, NY Accepting Medicare

5 Rheumatology doctors found. Showing 1 - 5

Dr. Marianna Gertsberg, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 180-05 Hillside Ave, Jamaica, NY 11432 Phone: 718-526-6300    Fax: 718-262-7064

Dr. Adriana Abrudescu, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 82-68 164th St, Jamaica, NY 11432 Phone: 718-883-3225    Fax: 718-883-6193

Dr. Amir Barkhodari, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 8900 Van Wyck Expy, Jamaica, NY 11418 Phone: 718-206-7708

Dr. Sabiha S Bandagi, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8268 164th St, Jamaica, NY 11432 Phone: 718-883-3225    Fax: 718-883-6193

Dr. Suneel Movva, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 18005 Hillside Ave, Jamaica, NY 11432 Phone: 718-526-6300

News Archive

Autism discovery may explain why disorder strikes boys four times more than girls

UCLA scientists have discovered a variant of a gene called CACNA1G that may increase a child's risk of developing autism, particularly in boys. The journal Molecular Psychiatry publishes the findings in its May 19 advance online edition.

Cedars-Sinai researchers move closer to developing biological pacemaker with new $3 million NIH grant

With a new $3 million grant from the National Institutes of Health, Cedars-Sinai Heart Institute investigators are moving closer to their goal of developing a biological pacemaker that can treat patients afflicted with slow heartbeats.

Undiagnosed hearing issues may lead to social isolation, cognitive impairment in seniors

Senior citizens with undiagnosed or untreated hearing problems are more likely to suffer from social isolation and cognitive impairment, a UBC study has found.

Shire receives Paragraph IV Notice Letter from Anchen over filing of ANDA for generic INTUNIV

Shire plc, the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter from Anchen Pharmaceuticals, Inc. advising of the filing of an Abbreviated New Drug Application for a generic version of Shire's 1 mg, 2 mg, 3 mg, and 4 mg guanfacine hydrochloride extended release tablets, INTUNIV(TM).

Novel drug could protect the brain during and after stroke

Neuroscientists at the University of Pittsburgh Brain Institute have identified a novel drug that could protect the brain during and after a stroke.

Read more Medical News

› Verified 1 days ago